Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
TherapeuticsMD, Inc. is a prominent pharmaceutical preparation manufacturer headquartered in the United States. Specialising in women’s health, the company focuses on developing innovative prescription products that address unmet medical needs. Since its founding, TherapeuticsMD has established a strong presence within the pharmaceutical industry, particularly in the areas of hormone therapy and reproductive health.
The company’s core offerings include a range of prescription medications designed to improve quality of life for women, with a focus on safety and efficacy. Known for its commitment to advancing women’s health, TherapeuticsMD has achieved notable milestones and holds a respected position in the market. Its strategic operations across major regions underscore its dedication to delivering specialised pharmaceutical solutions.
-19 vs industry average
TherapeuticsMD, Inc.’s score of 23 is lower than 26% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for TherapeuticsMD, Inc. yet.
As of the latest available data, TherapeuticsMD, Inc., a pharmaceutical preparation manufacturing company headquartered in the US, has not publicly disclosed specific absolute carbon emissions figures for its operations. Consequently, detailed information regarding its Scope 1, Scope 2, or Scope 3 emissions in kilograms of CO2e is not available.
Despite the absence of specific emissions data, TherapeuticsMD, Inc. has outlined its climate commitments. The company is committed to pursuing reduction targets and has indicated its engagement with initiatives relevant to climate action. However, precise details on their greenhouse gas reduction goals or any achievements in this area are not publicly detailed at this time. As a participant in the pharmaceutical industry, the company operates within a sector increasingly focused on environmental sustainability and the reduction of its carbon footprint.
No climate goals have been disclosed for TherapeuticsMD, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more